Nucleic Acid Testing Market Research Report by IMARC Group.com 2020-2025
According to the IMARC Group Nucleic acid testing (NAT) stands for a molecular method used to screen viruses, bacteria or pathogenic nucleic acid in the patient's blood, tissue, or urine. It is used for forensic examination and diagnosis of transfusion-borne infections, genetic disorders, and cancer. NAT includes sample pooling by nucleic acid (NA) extraction, target NA amplification, and target amplicon NA detection. Furthermore, the testing process also utilizes several kits and consumables for polymerase chain reaction (PCR), strand displacement amplification (SDA), transcription-mediated amplification (TMA), ligase chain reaction (LCR), and NA sequence-based amplification (NASBA) processes. NAT is widely adopted to classify illnesses that present no visible symptoms and to correct false reactive interpretations. Request For a Sample Report: https://www.imarcgroup.com/nucleic-acid-testing-market/requestsample The growing prevalence of infectious bacterial and ...